Pular para o conteúdo
Síndrome Senior-Loken
ORPHA:3156CID-10 · Q61.5CID-11 · 9B70DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Visão / ocularInício infânciaHerança AR
Também conhecida comoSLSNNPHP
Sinônimos clínicos: SLSN · Síndrome de displasia renal-aplasia da retina

A Síndrome de Senior-Loken (SLSN) é uma doença genética muito rara que afeta os olhos e os rins. Ela é autossômica recessiva, o que significa que a pessoa desenvolve a condição apenas se herdar uma cópia alterada de um gene de cada pai. Caracteriza-se pela combinação de nefroptise (NPHP), uma doença renal crônica, com distrofia da retina (um problema que afeta a retina dos olhos, a parte responsável por captar a luz).

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A Síndrome de Senior-Loken é uma doença genética muito rara que afeta principalmente a saúde dos rins e a visão. Ela combina uma alteração renal chamada nefronoptise com a distrofia da retina, o que pode levar à perda visual progressiva ao longo do tempo. A condição não consta na lista oficial de PCDTs de doenças raras do Ministério da Saúde nem possui remédios específicos dispensados pelo SUS. O cuidado na rede pública de saúde se concentra no suporte de reabilitação e no monitoramento das funções dos rins e dos olhos.

📋
Informacoes curadas por IA — podem conter imprecisoes

A Síndrome de Senior-Loken (SLSN) é uma doença genética muito rara que afeta os olhos e os rins. Ela é autossômica recessiva, o que significa que a pessoa desenvolve a condição apenas se herdar uma cópia alterada de um gene de cada pai. Caracteriza-se pela combinação de nefroptise (NPHP), uma doença renal crônica, com distrofia da retina (um problema que afeta a retina dos olhos, a parte responsável por captar a luz).

Publicações científicas
152 artigos
Último publicado: 2026 Mar 24

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, childhood, infancy
🏥
SUS: Cobertura mínimaScore: 15%
5 procedimentos SIGTAPCID-10: Q61.5
🇧🇷Dados SUS / DATASUS
EXAMES E PROCEDIMENTOS RELACIONADOS (5)
•
Cariótipo — bandas G, Q ou R
•
Pesquisa de microdeleções/microduplicações por FISH
•
Sequenciamento completo do exoma (WES)
•
Dosagem de alfa-fetoproteína
•
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
18 sintomas
🫘
Rins
11 sintomas
🦴
Ossos e articulações
8 sintomas
🫃
Digestivo
7 sintomas
🧠
Neurológico
7 sintomas
📏
Crescimento
2 sintomas

+ 6 sintomas em outras categorias

Características mais comuns

90%prev.
Deficiência visual
Muito frequente (99-80%)
90%prev.
Doença renal crônica estágio 5
Muito frequente (99-80%)
90%prev.
Baixa estatura
Muito frequente (99-80%)
90%prev.
Distrofia retiniana
Muito frequente (99-80%)
90%prev.
Doença renal crônica
Muito frequente (99-80%)
90%prev.
Atraso global do desenvolvimento
Muito frequente (99-80%)
62sintomas
Muito frequente (8)
Frequente (3)
Ocasional (5)
Sem dados (46)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 62 características clínicas mais associadas, ordenadas por frequência.

Deficiência visualVisual impairment
Muito frequente (99-80%)90%
Doença renal crônica estágio 5Stage 5 chronic kidney disease
Muito frequente (99-80%)90%
Baixa estaturaShort stature
Muito frequente (99-80%)90%
Distrofia retinianaRetinal dystrophy
Muito frequente (99-80%)90%
Doença renal crônicaChronic kidney disease
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico152PubMed
Últimos 10 anos65publicações
Pico202512 papers
Linha do tempo
2026Hoje · 2026🧪 2021Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

10 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

Curadoria gene-doença

fontes oficiais
NPHP3
CEP290Centrosomal protein of 290 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 5

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.

OUTRAS DOENÇAS (10)
Senior-Loken syndrome 6Leber congenital amaurosis 10Joubert syndrome 5Meckel syndrome, type 4
HGNC:29021UniProt:O15078
NPHP3Nephrocystin-3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Trafficking of myristoylated proteins to the cilium
MECANISMO DE DOENÇA

Nephronophthisis 3

An autosomal recessive disorder resulting in end-stage renal disease. It is characterized by polyuria, polydipsia, anemia. Onset of terminal renal failure occurr significantly later (median age, 19 years) than in juvenile nephronophthisis. Renal pathology is characterized by alterations of tubular basement membranes, tubular atrophy and dilation, sclerosing tubulointerstitial nephropathy, and renal cyst development predominantly at the corticomedullary junction.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
63.6 TPM
Fallopian Tube
51.7 TPM
Cervix Endocervix
50.2 TPM
Cervix Ectocervix
48.3 TPM
Nervo tibial
45.7 TPM
OUTRAS DOENÇAS (7)
NPHP3-related Meckel-like syndromenephronophthisis 3renal-hepatic-pancreatic dysplasia 1nephronophthisis 2
HGNC:7907UniProt:Q7Z494
CEP164Centrosomal protein of 164 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Nephronophthisis 15

An autosomal recessive disorder characterized by the association of nephronophthisis with Leber congenital amaurosis and retinal degeneration, often resulting in blindness during childhood. Additional features include seizures, cerebellar vermis hypoplasia, facial dysmorphism, bronchiectasis and liver failure. Nephronophthisis is a chronic tubulo-interstitial nephritis that progresses to end-stage renal failure.

OUTRAS DOENÇAS (2)
nephronophthisis 15Senior-Loken syndrome
HGNC:29182UniProt:Q9UPV0
INVSInversinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Nephronophthisis 2

An autosomal recessive disorder resulting in end-stage renal disease. It is characterized by early onset and rapid progression. Phenotypic manifestations include enlarged kidneys, chronic tubulo-interstitial nephritis, anemia, hyperkalemic metabolic acidosis. Some patients also display situs inversus. Pathologically, it differs from later-onset nephronophthisis by the absence of medullary cysts and thickened tubular basement membranes, and by the presence of cortical microcysts.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
13.0 TPM
Nervo tibial
11.8 TPM
Testículo
11.0 TPM
Útero
10.7 TPM
Linfócitos
10.3 TPM
OUTRAS DOENÇAS (2)
nephronophthisis 2Senior-Loken syndrome
HGNC:17870UniProt:Q9Y283
WDR19WD repeat-containing protein 19Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Cranioectodermal dysplasia 4

A disorder primarily characterized by craniofacial, skeletal and ectodermal abnormalities. Clinical features include craniosynostosis, narrow rib cage, short limbs, brachydactyly, hypoplastic and widely spaced teeth, sparse hair, skin laxity and abnormal nails. Nephronophthisis leading to progressive renal failure, hepatic fibrosis, heart defects, and retinitis pigmentosa have also been described.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
43.9 TPM
Tireoide
41.9 TPM
Fallopian Tube
40.6 TPM
Pituitária
39.0 TPM
Útero
37.9 TPM
OUTRAS DOENÇAS (9)
Senior-Loken syndrome 8asphyxiating thoracic dystrophy 5nephronophthisis 13cranioectodermal dysplasia 4
HGNC:18340UniProt:Q8NEZ3
IQCB1IQ calmodulin-binding motif-containing protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Senior-Loken syndrome 5

A renal-retinal disorder characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
66.9 TPM
Testículo
47.9 TPM
Cervix Endocervix
38.7 TPM
Ovário
38.5 TPM
Cervix Ectocervix
35.6 TPM
OUTRAS DOENÇAS (3)
Senior-Loken syndrome 5Senior-Loken syndromeLeber congenital amaurosis
HGNC:28949UniProt:Q15051
NPHP1Nephrocystin-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Nephronophthisis 1

An autosomal recessive inherited disease characterized by anemia, polyuria, polydipsia, isosthenuria and death in uremia. Symmetrical destruction of the kidneys involving both tubules and glomeruli occurs. The underlying pathology is a chronic tubulo-interstitial nephropathy with characteristic tubular basement membrane thickening and medullary cyst formation. Associations with extrarenal symptoms, especially ocular lesions, are frequent. The age at death ranges from about 4 to 15 years.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
27.2 TPM
Pituitária
15.1 TPM
Tireoide
10.2 TPM
Útero
7.7 TPM
Fallopian Tube
6.7 TPM
OUTRAS DOENÇAS (5)
nephronophthisis 1Senior-Loken syndrome 1Joubert syndrome with renal defectBardet-Biedl syndrome
HGNC:7905UniProt:O15259
TRAF3IP1TRAF3-interacting protein 1Disease-causing germline mutation(s) (loss of function) inTolerante
VIAS BIOLÓGICAS (1)
Intraflagellar transport
MECANISMO DE DOENÇA

Senior-Loken syndrome 9

A renal-retinal disorder characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
44.2 TPM
Artéria tibial
22.9 TPM
Nervo tibial
21.1 TPM
Útero
21.1 TPM
Fallopian Tube
20.3 TPM
OUTRAS DOENÇAS (3)
Senior-Loken syndrome 9short rib-polydactyly syndrome, Majewski typeSenior-Loken syndrome
HGNC:17861UniProt:Q8TDR0
SDCCAG8Serologically defined colon cancer antigen 8Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Senior-Loken syndrome 7

A renal-retinal disorder characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
21.2 TPM
Nervo tibial
15.1 TPM
Pulmão
13.8 TPM
Ovário
13.4 TPM
Fallopian Tube
13.1 TPM
OUTRAS DOENÇAS (4)
Bardet-Biedl syndrome 16Senior-Loken syndrome 7Senior-Loken syndromeBardet-Biedl syndrome
HGNC:10671UniProt:Q86SQ7
NPHP4Nephrocystin-4Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Signaling by HippoAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Nephronophthisis 4

An autosomal recessive inherited disease resulting in end-stage renal disease at age ranging between 6 and 35 years. It is a progressive tubulo-interstitial kidney disorder characterized by polydipsia, polyuria, anemia and growth retardation. The most prominent histological features are modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
22.3 TPM
Tireoide
21.5 TPM
Testículo
21.0 TPM
Nervo tibial
13.7 TPM
Skin Not Sun Exposed Suprapubic
12.0 TPM
OUTRAS DOENÇAS (4)
nephronophthisis 4Senior-Loken syndrome 4nephronophthisis 1Senior-Loken syndrome
HGNC:19104UniProt:O75161

Variantes genéticas (ClinVar)

1.593 variantes patogênicas registradas no ClinVar.

🧬 CEP290: NM_025114.4(CEP290):c.2498G>A (p.Trp833Ter) ()
🧬 CEP290: NM_025114.4(CEP290):c.4141G>T (p.Glu1381Ter) ()
🧬 CEP290: NM_025114.4(CEP290):c.423_424del (p.Lys142fs) ()
🧬 CEP290: NM_025114.4(CEP290):c.5981_5982insC (p.Leu1994_Asp1995insTer) ()
🧬 CEP290: NM_025114.4(CEP290):c.3985G>T (p.Glu1329Ter) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 3.608 variantes classificadas pelo ClinVar.

180
902
2526
Patogênica (5.0%)
VUS (25.0%)
Benigna (70.0%)
VARIANTES MAIS SIGNIFICATIVAS
WDR19: NM_025132.4(WDR19):c.1492C>T (p.Gln498Ter) [Pathogenic]
WDR19: NM_025132.4(WDR19):c.1339A>G (p.Lys447Glu) [Uncertain significance]
WDR19: NM_025132.4(WDR19):c.934A>G (p.Ile312Val) [Uncertain significance]
WDR19: NM_025132.4(WDR19):c.748T>C (p.Ser250Pro) [Uncertain significance]
WDR19: NM_025132.4(WDR19):c.1778-3T>C [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Senior-Loken

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Nenhum país com ensaio aberto no momento.

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
61 papers (10 anos)
#1

Systemic and Ocular Manifestations of a Ciliopathy: A Case Report of Renal-Retinal Involvement in Senior-Loken Syndrome.

Journal of clinical medicine2026 Mar 08

Background: Senior-Loken syndrome (SLS) is a rare autosomal recessive ciliopathy classically defined by the concurrence of nephronophthisis, frequently progressing to end-stage renal disease (ESRD), and retinal dystrophy, most commonly presenting as retinitis pigmentosa (RP). Given its phenotypic overlap with other renal-retinal syndromes, establishing a definitive diagnosis necessitates integrated clinical evaluation and molecular confirmation. Case Presentation: A 28-year-old Chinese female presented with a two-month history of binocular floaters. Her medical history was significant for ESRD of five years' duration, managed with maintenance hemodialysis. Ophthalmic assessment revealed retinal pigment mottling along the inferior temporal arcades and generalized arterial attenuation. Spectral-domain optical coherence tomography demonstrated outer retinal thinning with loss of the ellipsoid zone at corresponding locations. Perimetry confirmed visual field constriction, and full-field electroretinography showed severely reduced rod- and cone-mediated responses. Genetic testing was performed and a pathogenic variant in the NPHP1 gene was identified. Segregation studies confirmed both parents as heterozygous carriers, consistent with autosomal recessive inheritance. Collectively, these findings established a diagnosis of SLS. Conclusions: This case reinforces that SLS should be considered in the differential diagnosis of any young patient exhibiting RP alongside chronic kidney disease, particularly in the setting of early-onset ESRD. It also illustrates the essential role of a coordinated, multidisciplinary approach-encompassing nephrology, ophthalmology, and genetics-in diagnosing complex ciliopathies. Genetic confirmation not only validates the clinical diagnosis but also provides a foundation for family counseling, prognostic stratification, and future eligibility for gene-specific therapeutic trials.

#2

Publisher Correction: Long-read technologies identify a hidden LINE-1/ERV1 insertion in IQCB1 as causative variant for Senior-Løken syndrome.

NPJ genomic medicine2026 Mar 24
#3

Loss of C-Terminal Coiled-Coil Domains in SDCCAG8 Impairs Centriolar Satellites and Causes Defective Sperm Flagellum Biogenesis and Male Fertility.

Cells2025 Jul 23

Sperm flagellum defects are tightly associated with male infertility. Centriolar satellites are small multiprotein complexes that recruit satellite proteins to the centrosome and play an essential role in sperm flagellum biogenesis, but the precise mechanisms underlying this role remain unclear. Serologically defined colon cancer autoantigen protein 8 (SDCCAG8), which encodes a protein containing eight coiled-coil (CC) domains, has been associated with syndromic ciliopathies and male infertility. However, its exact role in male infertility remains undefined. Here, we used an Sdccag8 mutant mouse carrying a CC domains 5-8 truncated mutation (c.1351-1352insG p.E451GfsX467) that models the mutation causing Senior-Løken syndrome (c.1339-1340insG p.E447GfsX463) in humans. The homozygous Sdccag8 mutant mice exhibit male infertility characterized by multiple morphological abnormalities of the flagella (MMAF) and dysmorphic structures in the sperm manchette. A mechanistic study revealed that the SDCCAG8 protein is localized to the manchette and centrosomal region and interacts with PCM1, the scaffold protein of centriolar satellites, through its CC domains 5-7. The absence of the CC domains 5-7 in mutant spermatids destabilizes PCM1, which fails to recruit satellite components such as Bardet-Biedl syndrome 4 (BBS4) and centrosomal protein of 131 kDa (CEP131) to satellites, resulting in defective sperm flagellum biogenesis, as BBS4 and CEP131 are essential to flagellum biogenesis. In conclusion, this study reveals the central role of SDCCAG8 in maintaining centriolar satellite integrity during sperm flagellum biogenesis.

#4

The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.

International journal of molecular sciences2025 Jan 23

Visual electrophysiology is a valuable tool for evaluating the visual system in various systemic syndromes. This review highlights its clinical application in a selection of syndromes associated with hearing loss, mitochondrial dysfunction, obesity, and other multisystem disorders. Techniques such as full-field electroretinography (ffERG), multifocal electroretinography (mfERG), pattern electroretinography (PERG), visual evoked potentials (VEP), and electrooculography (EOG) offer insights into retinal and optic nerve function, often detecting abnormalities before clinical symptoms manifest. In hearing loss syndromes like Refsum disease, Usher syndrome (USH), and Wolfram syndrome (WS), electrophysiology facilitates the detection of early retinal changes that precede the onset of visual symptoms. For mitochondrial disorders such as maternally-inherited diabetes and deafness (MIDD), Kearns-Sayre syndrome (KSS), and neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome, these tests can be useful in characterizing retinal degeneration and optic neuropathy. In obesity syndromes, including Bardet-Biedl syndrome (BBS), Alström syndrome, and Cohen syndrome, progressive retinal degeneration is a hallmark feature. Electrophysiological techniques aid in pinpointing retinal dysfunction and tracking disease progression. Other syndromes, such as Alagille syndrome (AGS), abetalipoproteinemia (ABL), Cockayne syndrome (CS), Joubert syndrome (JS), mucopolysaccharidosis (MPS), Neuronal ceroid lipofuscinoses (NCLs), and Senior-Løken syndrome (SLS), exhibit significant ocular involvement that can be evaluated using these methods. This review underscores the role of visual electrophysiology in diagnosing and monitoring visual system abnormalities across a range of syndromes, potentially offering valuable insights for early diagnosis, monitoring of progression, and management.

#5

Unraveling the genetic spectrum of inherited deaf-blindness in Portugal.

Orphanet journal of rare diseases2025 Jan 14

Syndromic genetic disorders affecting vision can also cause hearing loss, and Usher syndrome is by far the most common etiology. However, many other conditions can present dual sensory impairment. Accurate diagnosis is essential for providing patients with genetic counseling, prognostic information, and appropriate resources. This study aimed to describe the genetic profile of combined inherited deaf-blindness in Portugal. This was a cross-sectional study conducted at a tertiary hospital in Portugal. Patients were identified through the national, web-based inherited retinal dystrophies registry (IRD-PT, retina.com.pt). Demographics, clinical, and genetic data were retrieved from individual patient records. Genetic variants were classified according to the American College of Medical Genetics and Genomics; only likely pathogenic or pathogenic variants were considered relevant for solved cases. Eighty-four patients (58.3% males; mean age 40.0 ± 17.9 years) from 71 families were included. Usher syndrome was the most frequent etiology (71.4%) followed by Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract syndrome (6.0%), Autosomal dominant optic atrophy plus (4.8%) and cone-rod dystrophy and hearing loss (4.8%). Other less frequent etiologies included Alport syndrome (2.4%), Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (2.4%), Heimler syndrome (2.4%), Senior-Loken syndrome (1.2%), Waardenburg syndrome (1.2%), Maternally inherited diabetes and deafness (1.2%), and Stickler syndrome (1.2%). The overall diagnostic yield of deleterious variants in our deaf-blind cohort was 73.2%. A total of 55 genetic variants were identified across 16 different genes; 11 of these variants are novel and herein reported for the first time. This is the first study to describe the genetic profile of patients with dual sensory impairment in Portugal, highlighting the genetic heterogeneity associated with inherited deaf-blindness. Usher syndrome was the most prevalent cause in this cohort. Nevertheless, several other less frequent causes must also be considered. This study showed a high diagnostic yield and reported 11 novel genetic variants, thereby contributing to expand the mutational spectrum of these conditions.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC72 artigos no totalmostrando 61

2026

Publisher Correction: Long-read technologies identify a hidden LINE-1/ERV1 insertion in IQCB1 as causative variant for Senior-Løken syndrome.

NPJ genomic medicine
2026

Systemic and Ocular Manifestations of a Ciliopathy: A Case Report of Renal-Retinal Involvement in Senior-Loken Syndrome.

Journal of clinical medicine
2025

Senior-Løken syndrome with IQCB1/NPHP5 mutation in an adult: a case report.

Journal of medical case reports
2025

Loss of C-Terminal Coiled-Coil Domains in SDCCAG8 Impairs Centriolar Satellites and Causes Defective Sperm Flagellum Biogenesis and Male Fertility.

Cells
2025

Ciliopathy: Senior-Løken Syndrome.

Advances in experimental medicine and biology
2025

Leber Congenital Amaurosis.

Advances in experimental medicine and biology
2025

Clinical and Genetic Characteristics of Senior-Loken Syndrome Patients in Korea.

Genes
2025

Bilateral cataracts as an early ocular manifestation of senior-loken syndrome.

Journal of the National Medical Association
2025

Nephronophthisis and Retinitis Pigmentosa (Senior-Loken Syndrome) After Living-Donor Kidney Transplantation: Twelve-Year Follow-Up in a Young Woman.

Journal of medical cases
2025

Senior-Loken Syndrome: Ocular Perspectives on Genetics, Pathogenesis, and Management.

Biomolecules
2025

Long-read technologies identify a hidden LINE-1/ERV1 insertion in IQCB1 as causative variant for Senior-Løken syndrome.

NPJ genomic medicine
2025

The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.

International journal of molecular sciences
2025

Unraveling the genetic spectrum of inherited deaf-blindness in Portugal.

Orphanet journal of rare diseases
2025

Variant Spectrum of Renal Ciliopathies in Turkish Cohort and Genotype-Phenotype Association Specifically in Autosomal Dominant Polycystic Kidney Disease.

Clinical genetics
2024

Spectrum and frequencies of extraocular features reported in CEP290-associated ciliopathy - A systematic review.

Journal francais d'ophtalmologie
2024

Genome sequencing identifies biallelic variants in SCLT1 in a patient with syndromic nephronophthisis: Reflections on the SCLT1-related ciliopathy spectrum.

American journal of medical genetics. Part A
2024

1H, 13C, and 15N resonance assignments and solution structure of the N-terminal divergent calponin homology (NN-CH) domain of human intraflagellar transport protein 54.

Biomolecular NMR assignments
2024

Diverse retinal-kidney phenotypes associated with NPHP1 homozygous whole-gene deletions in patients with kidney failure.

Journal of rare diseases (Berlin, Germany)
2024

Compound heterozygous WDR19 variants associated with nephronophthisis, Caroli disease, refractory epilepsy and congenital bilateral central blindness: Case report.

Heliyon
2023

Presumed uremic optic neuropathy in a patient with Senior-Loken syndrome.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2023

Autosomal Recessive Adolescent Syndromic Nephronophthisis Caused by a Novel Compound Heterozygous Pathogenic Variant.

The American journal of case reports
2024

Nephronophthisis: a pathological and genetic perspective.

Pediatric nephrology (Berlin, Germany)
2023

Successful Renal Transplantation in a Patient With Senior-Loken Syndrome and Antiphospholipid Syndrome: A Case Report.

Cureus
2023

NPHP1-Related ciliopathies: A new case and major review of the ophthalmic manifestations of 147 reported cases.

Clinical case reports
2023

A novel pathogenic variant of CEP164 in an infant with Senior-Loken syndrome.

Pediatric investigation
2023

A genotype-to-phenotype approach suggests under-reporting of single nucleotide variants in nephrocystin-1 (NPHP1) related disease (UK 100,000 Genomes Project).

Scientific reports
2024

Reduced cone photoreceptor function and subtle systemic manifestations in two siblings with loss of SCLT1.

Ophthalmic genetics
2023

Pathogenic Variants in CEP290 or IQCB1 Cause Earlier-Onset Retinopathy in Senior-Loken Syndrome Compared to Those in INVS, NPHP3, or NPHP4.

American journal of ophthalmology
2023

[Molecular genetics in diagnosis of Coats disease: combination of oligogenic variants associated with different forms of hereditary retinal dystrophy].

Vestnik oftalmologii
2022

Hemothorax From an Anomalous Bronchial Artery Bleed in an Infected Intralobar Pulmonary Sequestration.

Cureus
2022

In vitro modeling and rescue of ciliopathy associated with IQCB1/NPHP5 mutations using patient-derived cells.

Stem cell reports
2022

Ciliary Proteins Repurposed by the Synaptic Ribbon: Trafficking Myristoylated Proteins at Rod Photoreceptor Synapses.

International journal of molecular sciences
2022

Potpourri of retinopathies in rare eye disease - A case series.

Indian journal of ophthalmology
2022

Genetic analysis assists diagnosis of clinical systemic disease in children with excessive hyperopia.

BMC pediatrics
2022

Characterization of two novel knock-in mouse models of syndromic retinal ciliopathy carrying hypomorphic Sdccag8 mutations.

Zoological research
2021

Senior-Loken syndrome secondary to IQCB1 mutation in association with retinitis pigmentosa.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2021

SENIOR-LØKEN SYNDROME: A Case Series and Review of the Renoretinal Phenotype and Advances of Molecular Diagnosis.

Retina (Philadelphia, Pa.)
2021

Hepatic, pancreatic and renal manifestations of a ciliopathy.

Hepatobiliary &amp; pancreatic diseases international : HBPD INT
2021

Defective INPP5E distribution in NPHP1-related Senior-Loken syndrome.

Molecular genetics &amp; genomic medicine
2020

Senior-Løken syndrome misdiagnosed as nephrosclerosis related to hypertensive disorders of pregnancy.

BMJ case reports
2021

Ciliopathies and the Kidney: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2020

Senior-Løken syndrome and intracranial hypertension.

Ophthalmic genetics
2020

Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).

Transplant infectious disease : an official journal of the Transplantation Society
2020

Bardet-Biedl syndrome in two unrelated patients with identical compound heterozygous SCLT1 mutations.

CEN case reports
2020

Investigation of CEP290 genotype-phenotype correlations in a patient with retinitis pigmentosa, infertility, end-stage renal disease, and a novel mutation.

Ophthalmic genetics
2020

Copy number variations and multiallelic variants in Korean patients with Leber congenital amaurosis.

Molecular vision
2019

Generation of human induced pluripotent stem cells from peripheral blood mononuclear cells of a Senior-Loken syndrome patient.

Stem cell research
2019

Exudative Retinal Detachment due to Coats Disease in a Teenager with Senior-Loken Syndrome: Case Report and Review of Literature.

Cureus
2018

Rescue of cone function in cone-only Nphp5 knockout mouse model with Leber congenital amaurosis phenotype.

Molecular vision
2018

Compound heterozygous splice site variants in the SCLT1 gene highlight an additional candidate locus for Senior-Løken syndrome.

Scientific reports
2018

Senior-Løken syndrome with IQCB1 mutation in Taiwan.

The Kaohsiung journal of medical sciences
2018

Molecular Study of Nephronophthisis in 7 Unrelated Pakistani Families.

Iranian journal of kidney diseases
2018

New Insights into Cystic Kidney Diseases.

Contributions to nephrology
2017

Keeping an Eye on Bardet-Biedl Syndrome: A Comprehensive Review of the Role of Bardet-Biedl Syndrome Genes in the Eye.

Medical research archives
2017

Phenotypic Spectrum of Children with Nephronophthisis and Related Ciliopathies.

Clinical journal of the American Society of Nephrology : CJASN
2016

Fundus Examination Pointing to the Diagnosis of Senior-Loken Syndrome.

JAMA ophthalmology
2016

Targeted exome sequencing resolves allelic and the genetic heterogeneity in the genetic diagnosis of nephronophthisis-related ciliopathy.

Experimental &amp; molecular medicine
2016

Ciliopathy-associated IQCB1/NPHP5 protein is required for mouse photoreceptor outer segment formation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2016

Median sacral artery injury following a bone marrow biopsy successfully treated with selective trans-arterial embolization: a case report.

Journal of medical case reports
2015

Pinpointing clinical diagnosis through whole exome sequencing to direct patient care: a case of Senior-Loken syndrome.

Lancet (London, England)
2014

Senior- loken syndrome - a ciliopathy.

Journal of clinical and diagnostic research : JCDR
Ver todos os 72 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Senior-Loken.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Síndrome Senior-Loken e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A síndrome é causada por alterações genéticas com padrão de herança autossômica recessiva. Mutações em genes como CEP290, IQCB1 e na família NPHP afetam as proteínas dos cílios celulares e comprometem rins e retina.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

7 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:3156
    Orphanet
  2. GARD:322
    GARD (NIH)
  3. Q4354267
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Síndrome Senior-Loken. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/sindrome-senior-loken

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome Senior-Loken

ORPHA:3156 · MONDO:0017842
🇧🇷 Brasil SUS
SIGTAP
5 procedimentos
Geral
Prevalência
1-9 / 1 000 000
Herança
Autosomal recessive
CID-10
Q61.5 · Cisto medular do rim
CID-11
Início
Adolescent, Adult, Childhood, Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0403553
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara